Eloxx Pharmaceuticals Stock Performance News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eloxx pharmaceuticals stock performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eloxx Pharmaceuticals Stock Performance Today - Breaking & Trending Today

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Sees Significant Increase in Short Interest

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX – Get Free Report) was the target of a significant increase in short interest in the month of July. As of July 15th, there was short interest totalling 438,800 shares, an increase of 949.8% from the June 30th total of 41,800 shares. Based on an average trading volume of 1,170,000 shares, […] ....

United States , America Corp , News Ratings For Eloxx Pharmaceuticals Daily , Eloxx Pharmaceuticals , Eloxx Pharmaceuticals Inc , Eloxx Pharmaceuticals Stock Performance , Get Free Report , Free Report , Eloxx Pharmaceuticals Daily , Nasdaq Elox ,

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Short Interest Update

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX – Get Rating) saw a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 206,200 shares, a growth of 320.8% from the March 31st total of 49,000 shares. Currently, 14.1% of the company’s shares are short sold. Based on an average […] ....

United States , America Corp , Hedge Funds Weigh In On Eloxx Pharmaceuticals , News Ratings For Eloxx Pharmaceuticals Daily , Eloxx Pharmaceuticals Stock Performance , Eloxx Pharmaceuticals Company Profile , Eloxx Pharmaceuticals , Exchange Commission , Eloxx Pharmaceuticals Inc , Get Rating , Eloxx Pharmaceuticals Daily , Nasdaq Elox ,

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Short Interest Up 260.3% in March

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX – Get Rating) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 49,000 shares, a growth of 260.3% from the March 15th total of 13,600 shares. Based on an average daily volume of 239,300 shares, the short-interest ratio is […] ....

United States , News Ratings For Eloxx Pharmaceuticals Daily , Eloxx Pharmaceuticals Inc , Eloxx Pharmaceuticals , Eloxx Pharmaceuticals Stock Performance , America Corp , Get Rating , Eloxx Pharmaceuticals Daily , Nasdaq Elox ,

Eloxx Pharmaceuticals (NASDAQ:ELOX) Issues Earnings Results, Beats Estimates By $0.05 EPS

Eloxx Pharmaceuticals (NASDAQ:ELOX – Get Rating) released its earnings results on Monday. The company reported ($2.92) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.97) by $0.05, MarketWatch Earnings reports. Eloxx Pharmaceuticals Stock Performance Shares of ELOX traded up $0.11 during midday trading on Wednesday, reaching $3.36. The stock had a trading […] ....

United States , Eloxx Pharmaceuticals , News Ratings For Eloxx Pharmaceuticals Daily , Eloxx Pharmaceuticals Stock Performance , America Corp , Earnings History For Eloxx Pharmaceuticals , Eloxx Pharmaceuticals Inc , Get Rating , Marketwatch Earnings , Eloxx Pharmaceuticals Daily , Nasdaq Elox ,